This bill authorizes the Department of Defense (DoD) to establish a program within one year of enactment to expand domestic bioindustrial manufacturing capacity . The program aims to support the commercial-level production of critical biomanufactured products through competitive awards granted to eligible private entities. These awards can be used for establishing, upgrading, or retooling bioindustrial manufacturing facilities within the United States. When selecting award recipients, the Secretary of Defense must consider several criteria, including the technology's potential to improve domestic resilience and protect critical supply chains, its ability to meet warfighter demands, and the facility's repurposing capabilities. Additional considerations include promoting wide geographic distribution of facilities and their proximity to input materials or established biomanufacturing hubs. The Secretary will also establish oversight and reporting requirements for award recipients, detailing their progress, timelines, products, and agreements with the DoD. The bill mandates initial and annual reports to Congress, detailing the allocation plan, a list of awards made, and how these investments align with DoD priorities and national security. This program is set to terminate 10 years after enactment, though the President may extend it if deemed necessary for national economic and security needs.